Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

A potential role for islet amyloid polypeptide in the association of diabetes and pancreatic cancer

FY 2015-16

Summary
Pancreatic cancer is the fourth most common cause of cancer related death in Canada despite accounting for less than 2.5% of all cancers. The risk of pancreatic cancer is approximately double in both type 1 and type 2 diabetes. Changes in blood glucose and insulin levels in diabetes may contribute to pancreatic cancer. Islet amyloid polypeptide (IAPP) is a hormone produced in the pancreas with insulin that was recently found to have strong anti-tumour properties. IAPP is deficient in diabetes, and we hypothesize that this IAPP deficiency increases the risk of pancreatic cancer in diabetes. The purpose of this project is to determine whether changes in IAPP production by the pancreas, or changes in the IAPP receptor in the pancreas, affect the development of pancreatic cancer. The project findings could lead to new drugs for treatment, new methods for detecting, or possibly new ways to prevent such a lethal cancer.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
349826
Name
Taylor Austin
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
A potential role for islet amyloid polypeptide in the association of diabetes and pancreatic cancer
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Amylin; Cancer; Diabetes; Endocrinology; Iapp; Pancreatic Cancer; Pathogenesis; Pramlintide; Repurposing Drugs; Tumour Suppressor
Abstract
Pancreatic cancer is the fourth most common cause of cancer related death in Canada despite accounting for less than 2.5% of all cancers. The risk of pancreatic cancer is approximately double in both type 1 and type 2 diabetes. Changes in blood glucose and insulin levels in diabetes may contribute to pancreatic cancer. Islet amyloid polypeptide (IAPP) is a hormone produced in the pancreas with insulin that was recently found to have strong anti-tumour properties. IAPP is deficient in diabetes, and we hypothesize that this IAPP deficiency increases the risk of pancreatic cancer in diabetes. The purpose of this project is to determine whether changes in IAPP production by the pancreas, or changes in the IAPP receptor in the pancreas, affect the development of pancreatic cancer. The project findings could lead to new drugs for treatment, new methods for detecting, or possibly new ways to prevent such a lethal cancer.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Taylor, Austin
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~